ZA978413B - Hydroquinone derivative and pharmaceutical use thereof. - Google Patents

Hydroquinone derivative and pharmaceutical use thereof.

Info

Publication number
ZA978413B
ZA978413B ZA9708413A ZA978413A ZA978413B ZA 978413 B ZA978413 B ZA 978413B ZA 9708413 A ZA9708413 A ZA 9708413A ZA 978413 A ZA978413 A ZA 978413A ZA 978413 B ZA978413 B ZA 978413B
Authority
ZA
South Africa
Prior art keywords
group
hydrogen atom
alkyl group
oxo
hydroquinone derivative
Prior art date
Application number
ZA9708413A
Other languages
English (en)
Inventor
Yoshiaki Isobe
Yuso Goto
Masanori Tobe
Osamu Takahashi
Original Assignee
Japan Energy Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Energy Corp filed Critical Japan Energy Corp
Publication of ZA978413B publication Critical patent/ZA978413B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA9708413A 1996-09-19 1997-09-18 Hydroquinone derivative and pharmaceutical use thereof. ZA978413B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP24827296 1996-09-19

Publications (1)

Publication Number Publication Date
ZA978413B true ZA978413B (en) 1998-03-26

Family

ID=17175664

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9708413A ZA978413B (en) 1996-09-19 1997-09-18 Hydroquinone derivative and pharmaceutical use thereof.

Country Status (13)

Country Link
US (2) US5821247A (de)
EP (1) EP0831092B1 (de)
AT (1) ATE194838T1 (de)
AU (1) AU716992B2 (de)
CA (1) CA2216288C (de)
DE (1) DE69702580T2 (de)
DK (1) DK0831092T3 (de)
ES (1) ES2149548T3 (de)
GR (1) GR3034418T3 (de)
NO (1) NO313413B1 (de)
NZ (1) NZ328769A (de)
PT (1) PT831092E (de)
ZA (1) ZA978413B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP2002002582A0 (en) * 1999-12-23 2002-09-30 Nitromed Inc Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
WO2004026842A1 (ja) * 2002-09-20 2004-04-01 Sumitomo Pharmaceuticals Co., Ltd. 新規ウラシル誘導体及びその医薬用途
EA038941B1 (ru) 2007-11-06 2021-11-12 ПиТиСи ТЕРАПЬЮТИКС, ИНК. ПРОИЗВОДНЫЕ 4-(п-ХИНОНИЛ)-2-ГИДРОКСИБУТАНАМИДА ДЛЯ ЛЕЧЕНИЯ МИТОХОНДРИАЛЬНЫХ ЗАБОЛЕВАНИЙ
DK3233786T3 (da) 2014-12-16 2022-05-09 Ptc Therapeutics Inc Polymorfe og amorfe former af (r)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6- dioxocyclohexa-1,4-dienyl)butanamid
US10815211B2 (en) 2015-10-08 2020-10-27 Khondrion Ip B.V. Compounds for treating mitochondrial disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5661153A (en) * 1994-07-19 1997-08-26 Japan Energy Corporation 1-arylpyrimidine derivatives and pharmaceutical use thereof

Also Published As

Publication number Publication date
EP0831092A3 (de) 1998-04-08
CA2216288A1 (en) 1998-03-19
AU3760197A (en) 1998-03-26
DE69702580D1 (de) 2000-08-24
CA2216288C (en) 2006-02-07
NZ328769A (en) 1998-07-28
DE69702580T2 (de) 2001-03-08
PT831092E (pt) 2000-10-31
NO974313L (no) 1998-03-20
EP0831092B1 (de) 2000-07-19
ATE194838T1 (de) 2000-08-15
DK0831092T3 (da) 2000-10-16
ES2149548T3 (es) 2000-11-01
GR3034418T3 (en) 2000-12-29
AU716992B2 (en) 2000-03-16
NO313413B1 (no) 2002-09-30
EP0831092A2 (de) 1998-03-25
US5877318A (en) 1999-03-02
US5821247A (en) 1998-10-13
NO974313D0 (no) 1997-09-18

Similar Documents

Publication Publication Date Title
CA2219675A1 (en) Pentacyclic compound
AU2267195A (en) Dc-89 derivative
WO2001072728A3 (en) Novel piperazine derivatives
CA2234096A1 (en) 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives
DE69526918D1 (de) Arzneimittel gegen spinocerebellare degeneration
AU5504694A (en) Substituted amic acid derivatives
WO2002032901A3 (en) Bridged piperazine derivatives
CA2152817A1 (en) Novel Pyridone Carboxylic Acid Derivatives
EP0292576A4 (en) Anti-ulcerous agent containing chalcone derivative as effective ingredient and novel chalcone derivatives
GR3034418T3 (en) Hydroquinone derivative and pharmaceutical use thereof
MX9606523A (es) Derivados del acido fosfonico.
IL114989A0 (en) Camptothecin derivatives, preparation thereof and antitumor agents
CA2262997A1 (en) Pharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cells
EP0335979A4 (en) Thienopyrimidine derivatives
EP0790247A4 (de) Tetrahydroisochinolin-derivate und diese enthaltende arzneimittel
EP0358091A3 (de) 2-Zyklohexylpropanal-Derivate und diese enthaltende Parfümeriezusammenstellungen
EP0997463A4 (de) Naphthyridinderivate
ES2151442B1 (es) Nuevo derivado del bencenoetanol.
BG102429A (en) Derivatives of 5-naphthalen-1-yl-1,3-dioxan, their preparation and usage as therapeutical means
ES488134A1 (es) Un procedimiento para la preparacion de derivados de 6,7- benzomorfan
TW346483B (en) Benzene derivatives
EP0376162A3 (de) Mittel zur Verhinderung von Zahnbelagbildung
EP1048649A4 (de) 5-arylpyrrol-derivate
TW329388B (en) Intraocular irrigating solution
EP1632228A4 (de) Medizinische zusammensetzung mit einer triazol-verbindung